HeraMED Limited (ASX:HMD)

Australia · Delayed Price · Currency is AUD

0.0380

+0.0020 (5.56%)

Jun 26, 2026, 1:05 PM AEST

442.86% (1Y)

Market Cap	43.98M +458.1%
Revenue (ttm)	431.61K -10.3%
Net Income	-4.13M
EPS	-0.00
Shares Out	1.16B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	624,747
Open	0.0350
Previous Close	0.0360
Day's Range	0.0350 - 0.0380
52-Week Range	0.0070 - 0.0550
Beta	0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About HeraMED

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women’s health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Haw... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2011

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol HMD

Full Company Profile

Financial Performance

In 2025, HeraMED's revenue was 431,605, a decrease of -10.31% compared to the previous year's 481,227. Losses were -4.13 million, -24.75% less than in 2024.

Financial Statements